The interaction of Hageman factor and immune complexes

Area of Science:

• Immunology
• Hematology
• Biochemistry

Background:

• Hageman factor (coagulation factor XII) is a key component of the intrinsic pathway of blood coagulation.
• Its potential role in immune responses, particularly in interaction with immune complexes, has been investigated.
• Understanding these interactions is crucial for elucidating inflammatory and coagulation processes.

Purpose of the Study:

• To investigate the interaction between Hageman factor and various immunologic reactants.
• To determine if immune complexes can activate Hageman factor directly.
• To identify potential triggers for Hageman factor activation in immunological contexts.

Main Methods:

• Radiolabeling of Hageman factor to track binding and degradation.
• Incubation of Hageman factor with diverse immune aggregates, including antigen-antibody complexes and aggregated immunoglobulins.
• Assays for Hageman factor activation, such as prekallikrein conversion and clotting time measurements.
• Testing of isolated Hageman factor versus Hageman factor in plasma/serum.

Main Results:

• No binding of radiolabeled Hageman factor to immune aggregates was observed.
• No depletion or detectable cleavage of Hageman factor occurred upon incubation with immune complexes.
• Isolated Hageman factor showed higher sensitivity to activation but was not consistently activated by immunologic reactants.
• Bacterial contamination in immunoglobulin preparations was identified as the sole activator of Hageman factor.

Conclusions:

• Hageman factor does not directly interact with or get activated by immune complexes.
• The observed activation of Hageman factor in previous studies may have been due to bacterial contamination.
• This finding clarifies the role of Hageman factor in immune responses, separating it from direct immune complex interactions.